In CKD, a condition with known insulin resistance and IGF-1 deficiency, ursolic acid blocked CKD induced muscle atrophy by suppressing myostatin expression, inflammatory responses associated with NF-κB activations, and by stimulating protein synthesis [165]. Here, MSTN is linked to chronic kidney disease.